3.連結財務諸表及び主な注記

(1)連結貸借対照表

 

 

 

 

 

 

 

 

 

 

 

(単位:千円)

 

 

 

 

 

 

 

 

 

 

前連結会計年度

(2025年3月31日)

当連結会計年度

(2026年3月31日)

資産の部

 

 

 

流動資産

 

 

 

 

現金及び預金

2,850,379

2,627,404

 

 

受取手形及び売掛金

1,297,618

1,135,657

 

 

電子記録債権

106,871

234,683

 

 

商品及び製品

239,420

215,312

 

 

仕掛品

1,416,295

1,561,467

 

 

原材料及び貯蔵品

500,000

609,808

 

 

その他

175,205

225,135

 

 

貸倒引当金

115

109

 

 

流動資産合計

6,585,675

6,609,359

 

固定資産

 

 

 

 

有形固定資産

 

 

 

 

 

建物及び構築物

2,962,565

3,014,264

 

 

 

 

減価償却累計額

2,048,538

2,163,411

 

 

 

 

建物及び構築物(純額)

914,027

850,852

 

 

 

機械装置及び運搬具

3,463,674

3,454,819

 

 

 

 

減価償却累計額

3,029,173

2,988,423

 

 

 

 

機械装置及び運搬具(純額)

434,501

466,395

 

 

 

土地

1,457,525

1,669,535

 

 

 

リース資産

217,168

216,199

 

 

 

 

減価償却累計額

166,568

163,719

 

 

 

 

リース資産(純額)

50,600

52,480

 

 

 

建設仮勘定

19,311

26,076

 

 

 

その他

630,042

691,350

 

 

 

 

減価償却累計額

561,805

610,184

 

 

 

 

その他(純額)

68,236

81,166

 

 

 

有形固定資産合計

2,944,202

3,146,505

 

 

無形固定資産

 

 

 

 

 

特許権

10,050

9,288

 

 

 

リース資産

2,597

13,326

 

 

 

その他

20,723

21,014

 

 

 

無形固定資産合計

33,371

43,629

 

 

投資その他の資産

 

 

 

 

 

投資有価証券

124,970

126,859

 

 

 

出資金

130

130

 

 

 

繰延税金資産

97,934

173,211

 

 

 

その他

62,556

71,486

 

 

 

貸倒引当金

5,993

5,993

 

 

 

投資その他の資産合計

279,598

365,693

 

 

固定資産合計

3,257,172

3,555,828

 

資産合計

9,842,848

10,165,188

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(単位:千円)

 

 

 

 

 

 

 

 

 

 

前連結会計年度

(2025年3月31日)

当連結会計年度

(2026年3月31日)

負債の部

 

 

 

流動負債

 

 

 

 

支払手形及び買掛金

163,081

154,172

 

 

電子記録債務

327,261

276,860

 

 

1年内返済予定の長期借入金

552,060

523,550

 

 

リース債務

13,088

20,919

 

 

未払法人税等

144,385

20,591

 

 

賞与引当金

138,296

96,211

 

 

その他

301,091

266,547

 

 

流動負債合計

1,639,264

1,358,852

 

固定負債

 

 

 

 

長期借入金

894,330

940,570

 

 

リース債務

30,543

37,515

 

 

再評価に係る繰延税金負債

23,719

23,719

 

 

株式給付引当金

118,936

122,641

 

 

退職給付に係る負債

427,738

429,673

 

 

その他

515

515

 

 

固定負債合計

1,495,783

1,554,636

 

負債合計

3,135,047

2,913,489

純資産の部

 

 

 

株主資本

 

 

 

 

資本金

1,939,834

1,939,834

 

 

資本剰余金

517,064

517,091

 

 

利益剰余金

4,328,704

4,801,217

 

 

自己株式

256,105

282,571

 

 

株主資本合計

6,529,498

6,975,572

 

その他の包括利益累計額

 

 

 

 

その他有価証券評価差額金

60,473

61,717

 

 

土地再評価差額金

26,474

26,474

 

 

為替換算調整勘定

91,354

187,935

 

 

その他の包括利益累計額合計

178,302

276,126

 

純資産合計

6,707,800

7,251,699

負債純資産合計

9,842,848

10,165,188

 

 

E00584 35830 オーベクス株式会社 AuBEX CORPORATION 通期第1号参考様式 [日本基準](連結) Japan GAAP true cte cte 2025-04-01 2026-03-31 FY 2026-03-31 2024-04-01 2025-03-31 2025-03-31 1 false false false 35830 2026-05-12 35830 2025-04-01 2026-03-31 35830 2025-04-01 2026-03-31 jppfs_cor:CapitalStockMember 35830 2025-04-01 2026-03-31 jppfs_cor:CapitalSurplusMember 35830 2025-04-01 2026-03-31 jppfs_cor:ForeignCurrencyTranslationAdjustmentMember 35830 2025-04-01 2026-03-31 jpcrp_cor:ReconcilingItemsMember 35830 2025-04-01 2026-03-31 jpcrp_cor:ReportableSegmentsMember 35830 2025-04-01 2026-03-31 jppfs_cor:RetainedEarningsMember 35830 2025-04-01 2026-03-31 jppfs_cor:RevaluationReserveForLandMember 35830 2025-04-01 2026-03-31 jppfs_cor:ShareholdersEquityMember 35830 2025-04-01 2026-03-31 jppfs_cor:TreasuryStockMember 35830 2025-04-01 2026-03-31 tse-acedjpfr-35830:MedicalProductsReportableSegmentsMember 35830 2025-04-01 2026-03-31 tse-acedjpfr-35830:TechnologicalProductsReportableSegmentsMember 35830 2025-04-01 2026-03-31 jppfs_cor:ValuationAndTranslationAdjustmentsMember 35830 2025-04-01 2026-03-31 jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember 35830 2026-03-31 35830 2026-03-31 jppfs_cor:CapitalStockMember 35830 2026-03-31 jppfs_cor:CapitalSurplusMember 35830 2026-03-31 jppfs_cor:ForeignCurrencyTranslationAdjustmentMember 35830 2026-03-31 jpcrp_cor:ReconcilingItemsMember 35830 2026-03-31 jpcrp_cor:ReportableSegmentsMember 35830 2026-03-31 jppfs_cor:RetainedEarningsMember 35830 2026-03-31 jppfs_cor:RevaluationReserveForLandMember 35830 2026-03-31 jppfs_cor:ShareholdersEquityMember 35830 2026-03-31 jppfs_cor:TreasuryStockMember 35830 2026-03-31 tse-acedjpfr-35830:MedicalProductsReportableSegmentsMember 35830 2026-03-31 tse-acedjpfr-35830:TechnologicalProductsReportableSegmentsMember 35830 2026-03-31 jppfs_cor:ValuationAndTranslationAdjustmentsMember 35830 2026-03-31 jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember 35830 2024-04-01 2025-03-31 35830 2024-04-01 2025-03-31 jppfs_cor:CapitalStockMember 35830 2024-04-01 2025-03-31 jppfs_cor:CapitalSurplusMember 35830 2024-04-01 2025-03-31 jppfs_cor:ForeignCurrencyTranslationAdjustmentMember 35830 2024-04-01 2025-03-31 jpcrp_cor:ReconcilingItemsMember 35830 2024-04-01 2025-03-31 jpcrp_cor:ReportableSegmentsMember 35830 2024-04-01 2025-03-31 jppfs_cor:RetainedEarningsMember 35830 2024-04-01 2025-03-31 jppfs_cor:RevaluationReserveForLandMember 35830 2024-04-01 2025-03-31 jppfs_cor:ShareholdersEquityMember 35830 2024-04-01 2025-03-31 jppfs_cor:TreasuryStockMember 35830 2024-04-01 2025-03-31 tse-acedjpfr-35830:MedicalProductsReportableSegmentsMember 35830 2024-04-01 2025-03-31 tse-acedjpfr-35830:TechnologicalProductsReportableSegmentsMember 35830 2024-04-01 2025-03-31 jppfs_cor:ValuationAndTranslationAdjustmentsMember 35830 2024-04-01 2025-03-31 jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember 35830 2025-03-31 35830 2025-03-31 jppfs_cor:CapitalStockMember 35830 2025-03-31 jppfs_cor:CapitalSurplusMember 35830 2025-03-31 jppfs_cor:ForeignCurrencyTranslationAdjustmentMember 35830 2025-03-31 jpcrp_cor:ReconcilingItemsMember 35830 2025-03-31 jpcrp_cor:ReportableSegmentsMember 35830 2025-03-31 jppfs_cor:RetainedEarningsMember 35830 2025-03-31 jppfs_cor:RevaluationReserveForLandMember 35830 2025-03-31 jppfs_cor:ShareholdersEquityMember 35830 2025-03-31 jppfs_cor:TreasuryStockMember 35830 2025-03-31 tse-acedjpfr-35830:MedicalProductsReportableSegmentsMember 35830 2025-03-31 tse-acedjpfr-35830:TechnologicalProductsReportableSegmentsMember 35830 2025-03-31 jppfs_cor:ValuationAndTranslationAdjustmentsMember 35830 2025-03-31 jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember 35830 2024-03-31 35830 2024-03-31 jppfs_cor:CapitalStockMember 35830 2024-03-31 jppfs_cor:CapitalSurplusMember 35830 2024-03-31 jppfs_cor:ForeignCurrencyTranslationAdjustmentMember 35830 2024-03-31 jppfs_cor:RetainedEarningsMember 35830 2024-03-31 jppfs_cor:RevaluationReserveForLandMember 35830 2024-03-31 jppfs_cor:ShareholdersEquityMember 35830 2024-03-31 jppfs_cor:TreasuryStockMember 35830 2024-03-31 jppfs_cor:ValuationAndTranslationAdjustmentsMember 35830 2024-03-31 jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember iso4217:JPY xbrli:pure